High Throughput Screening 2018-2023: Global Market Value to Reach $21.7 Billion by 2023 with Opportunities in Emerging Markets
DUBLIN, May 21, 2018 /PRNewswire/ --
The "High Throughput Screening Market by Technology, Application, Product, End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%.
The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.
On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.
On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.
North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.
The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Scope of the Study
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Stakeholders
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 High-Throughput Screening: Market Overview
4.2 HTS Market: Developed vs Developing Countries (2018 vs 2023)
4.3 Geographic Snapshot: HTS Market (2017)
4.4 Geographic Mix: HTS Market
4.5 HTS Market, By Product & Services (2018 vs 2023)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
5.2.1.2 Government Funding and Venture Capital Investments
5.2.1.3 Increasing R&D Spending
5.2.1.4 Technological Advancements
5.2.2 Market Restraints
5.2.2.1 Capital-Intensive Nature of HTS
5.2.2.2 Complexities in the Field of Assay Development
5.2.3 Market Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Research Activities in Toxicology and Stem Cells
5.2.4 Market Challenges
5.2.4.1 Dearth of Skilled Operators
6 Industry Insights
6.1 Introduction
6.2 Technological Trends
6.2.1 Label-Free Technology
6.2.2 Automation & Miniaturization
6.2.3 Microfluidics
6.3 HTS in Drug Discovery Process
7 High-Throughput Screening Market, By Product & Service
7.1 Introduction
7.2 Reagents & Assay Kits
7.3 Instruments
7.4 Consumables & Accessories
7.5 Software
7.6 Services
8 High-Throughput Screening Market, By Technology
8.1 Introduction
8.2 Cell-Based Assays
8.2.1 2D Cell Culture
8.2.2 3D Cell Culture
8.2.2.1 Scaffold-Based Technology
8.2.2.1.1 Hydrogels
8.2.2.1.1.1 Animal-Derived Hydrogels
8.2.2.1.1.1.1 Matrigel
8.2.2.1.1.1.2 Collagen
8.2.2.1.1.2 Synthetic Hydrogels
8.2.2.1.1.3 Alginate/Agarose
8.2.2.1.2 Inert Matrix/Solid Scaffolds
8.2.2.1.3 Micropatterned Surfaces
8.2.2.2 Scaffold-Free Technology
8.2.2.2.1 Microplates
8.2.2.2.2 Hanging-Drop Plates
8.2.2.2.3 Ultra-Low Binding Plates
8.2.2.2.4 Other Scaffold-Free Technologies
8.2.3 Perfusion Cell Culture
8.3 Lab-On-A-Chip
8.4 Ultra-High-Throughput Screening
8.5 Bioinformatics
8.6 Label-Free Technology
9 High-Throughput Screening Market, By Application
9.1 Introduction
9.2 Target Identification and Validation
9.3 Primary and Secondary Screening
9.4 Toxicology Assessment
9.5 Other Applications
10 High-Throughput Screening Market, By End User
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Companies
10.3 Academic and Government Institutes
10.4 Contract Research Organizations (CRO)
10.5 Other End Users
11 High-Throughput Screening Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Latin America
11.6 Middle East and Africa
12 Competitive Landscape
12.1 Introduction
12.2 Market Leadership Analysis
12.3 Competitive Scenario
12.3.1 Product Launches and Upgrades
12.3.2 Partnerships, Collaborations, and Agreements
12.3.3 Expansions
12.3.4 Acquisitions
12.3.5 Other Developments
13 Company Profiles
13.1 Thermo Fisher Scientific Inc.
13.2 Agilent Technologies, Inc.
13.3 Danaher Corporation
13.4 Perkinelmer, Inc.
13.5 Tecan Group
13.6 Axxam S.P.A.
13.7 Bio-Rad Laboratories
13.8 Merck Group
13.9 Hamilton Company
13.10 Corning Incorporated
13.11 Biotek Instruments
13.12 Aurora Biomed
For more information about this report visit https://www.researchandmarkets.com/research/l5fm6k/high_throughput?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article